Why Farbe Firma is the Top Manufacturer of Cholecalciferol (Vitamin D3) Injection
- Maulik Sudani
- 6 hours ago
- 10 min read
Last Updated: July 3, 2026
TL;DR: Cholecalciferol (Vitamin D3) Injection - a sterile solution of cholecalciferol, the fat-soluble anti-rachitic vitamin D3, a secosteroid prohormone the liver and kidney convert into the calcium-regulating hormone calcitriol, supplied commonly as a high-potency 300,000 IU/mL (7.5 mg/mL) oily solution in an amber glass ampoule for deep intramuscular depot dosing - is the vitamin clinicians use to correct severe vitamin D deficiency, nutritional rickets, osteomalacia and the deficiency of malabsorption in a single injected dose. Because a fat-soluble vitamin is dissolved in a non-aqueous oil vehicle and injected deep into muscle, each ampoule must deliver a sterile, correctly potent, oxidation-free solution, with the high-potency HPLC assay and vitamin D-related substances, the oil-vehicle quality, an antioxidant and nitrogen-protection system, colour and clarity, particulate and endotoxin, a validated dry-heat or aseptic sterilisation route and verified container-closure integrity all mattering to potency and safety. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Cholecalciferol (Vitamin D3) Injection at our Gujarat, India facility and supplies it to endocrinology, paediatric, orthopaedic and hospital-pharmacy services, tenders, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Fat-soluble anti-rachitic vitamin (vitamin D3) - cholecalciferol is a secosteroid prohormone hydroxylated in the liver to 25-hydroxyvitamin D3 and in the kidney to active 1,25-dihydroxyvitamin D3 (calcitriol), regulating calcium and phosphate absorption and bone mineralisation, and Cholecalciferol (Vitamin D3) Injection (a high-potency 300,000 IU/mL oily solution given by deep intramuscular injection) demands an accurately potent, oxidation-free, particle-free solution in every ampoule.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection and clean-oil handling, dedicated non-aqueous compounding and ampoule filling under nitrogen with an antioxidant, control of the high-potency vitamin D3 assay and related substances by HPLC, oil-vehicle acid and peroxide value, colour and clarity, particulate and endotoxin, validated dry-heat or aseptic sterilisation, with container-closure integrity verification on every batch.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, ICH Q1B photostability data, forced-degradation data, sterilisation and container-closure data, drug master files and CEP-style documentation for registrations including ministry-of-health, hospital-formulary and institutional tenders.
End-to-end CDMO services: Sterile oily-vitamin ampoule contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tamper-evident tender-ready packaging and import/export coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Cholecalciferol (Vitamin D3) Injection Demands a Premium Manufacturer
Cholecalciferol (Vitamin D3) Injection holds an established place in endocrinology, paediatrics and bone medicine across many markets. It is the therapy a clinician turns to when a patient's vitamin D store is severely depleted and the oral route is unreliable or too slow - in nutritional rickets in children, in osteomalacia in adults, in the profound deficiency of intestinal malabsorption, bariatric surgery, and chronic liver or kidney disease, and wherever a single supervised long-acting depot dose is preferred to daily oral supplements. Cholecalciferol is not itself the active agent but a fat-soluble secosteroid prohormone: once injected it is hydroxylated in the liver to 25-hydroxyvitamin D3, the form measured to judge vitamin D status, and then in the kidney to 1,25-dihydroxyvitamin D3, or calcitriol, the hormone that drives intestinal calcium and phosphate absorption and normal bone mineralisation. What makes the parenteral form distinctive is that it lays down a fat-soluble depot in muscle from which the vitamin is released over weeks to months, so that one deep intramuscular injection can correct a deficiency that would otherwise need months of daily dosing - and that depends on an ampoule whose potency is exactly what the label claims.
That clinical reality places real demands on the manufacturer. Cholecalciferol (Vitamin D3) Injection is a fat-soluble vitamin, so it is not dissolved in water but in a non-aqueous oily vehicle - a fractionated vegetable oil, arachis (groundnut) oil or ethyl oleate - and presented, for example, as 300,000 IU in a 1 mL ampoule or 600,000 IU in a 2 mL ampoule (with 1 mg of cholecalciferol equal to 40,000 IU), given by deep intramuscular injection only, never intravenously, because an oil must not enter a vein. The defining quality challenge is that vitamin D3 is highly sensitive to oxidation, heat and light: exposed to air or ultraviolet light it isomerises and degrades to pre-vitamin D, tachysterol and other inactive substances, so the solution is compounded and filled under nitrogen, an antioxidant such as alpha-tocopherol or butylated hydroxytoluene is added, the ampoule is amber and light-protected, and a measured potency overage is built in so the labelled IU is delivered across the whole shelf life. Because the vehicle is an oil, the product cannot simply be moist-heat sterilised like an aqueous solution; sterility is achieved by validated dry-heat sterilisation or by sterile filtration of the oil followed by aseptic filling, and the oil itself must be qualified for low peroxide value, low acid value and low moisture. The high potency per millilitre means the assay must be accurate at a very high concentration, the fill must be exact, and the viscosity of the oil must still allow a clean, injectable dose. Choosing a Cholecalciferol (Vitamin D3) Injection manufacturer that treats oxidation and light control, oil-vehicle qualification and high-potency assay accuracy as core disciplines is what protects the patient at the point of care.
What Sets a World-Class Cholecalciferol (Vitamin D3) Injection Manufacturer Apart
A world-class manufacturer of Cholecalciferol (Vitamin D3) Injection invests in three areas that weaker suppliers underfund: precise, validated control of a very high-potency vitamin D3 assay and the vitamin D-related substances by HPLC - confirming the labelled IU and detecting the pre-vitamin D, tachysterol and oxidation products a fat-soluble vitamin readily forms; a robust non-aqueous sterile process, built on a qualified oil vehicle and validated dry-heat or aseptic sterilisation because an oily solution cannot be terminally moist-heat sterilised in the ordinary way; and tender-ready dossier support, including the potency-overage justification, photostability and oxidation data, for a vitamin procured through paediatric, endocrine and ministry-of-health channels. It starts with the raw materials - pharmacopoeial cholecalciferol of controlled potency and low pre-existing degradation, often supplied as a stabilised concentrate, the antioxidant, and a pharmaceutical-grade injectable oil qualified for acid value, peroxide value and moisture - each sourced from qualified, audited suppliers with full assay, related-substance and impurity profiling and certificates of analysis verified by the receiving laboratory before the material enters production. Because the value of the product is a precise, stable, high dose of an easily oxidised vitamin, the assay, the related substances and the oxidation and stability data are treated as central evidence rather than supporting annexes.
Compounding and filling then have to build - and defend - an accurately potent, oxidation-free oily solution. The cholecalciferol is dissolved in the qualified oil under gentle warming where needed, the antioxidant incorporated, and the whole operation carried out under a nitrogen blanket, protected from light, to keep the vitamin intact. Because the vehicle is an oil, the solution is sterilised by a validated route appropriate to a non-aqueous product - dry-heat sterilisation, or sterile filtration of the oil followed by aseptic filling into amber glass ampoules under ISO Class 5 conditions with a nitrogen headspace, the ampoules then sealed - rather than by the routine terminal moist-heat autoclave used for aqueous injectables. Filled units are 100 % inspected for fill, seal, clarity and particulate; in-process and release testing confirm the cholecalciferol assay and the delivered IU per millilitre, the vitamin D-related substances by HPLC, the acid and peroxide value of the oil, colour and clarity against defined limits, visible and sub-visible particulate matter, deliverable volume, and that endotoxin is held well within limits so the solution is safe for intramuscular use. Because the product is a high-potency, easily oxidised vitamin in oil, the assay, the related substances and the peroxide value are confirmed together, before and after sterilisation, so the solution that leaves the plant is the same clear, correctly potent, oxidation-free oily solution the specification requires - delivering the full labelled IU with no rancidity and no out-of-limit degradation in the ampoule across shelf life.
Quality Systems Behind Every Cholecalciferol (Vitamin D3) Injection
Every Farbe Firma Cholecalciferol (Vitamin D3) Injection batch is released only after a full stack of quality checks: stability-indicating HPLC assay of cholecalciferol against reference standards with confirmation of the delivered IU, control of the vitamin D-related substances including pre-vitamin D and tachysterol, the acid value and peroxide value of the oil vehicle, colour and clarity of solution against defined limits, deliverable volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the amber glass ampoule. Certificates of analysis are issued with full traceability back to each cholecalciferol lot, the oil-vehicle lot, the primary-packaging lot and the qualified person responsible for release. Because the product is a non-aqueous, oxidation-prone, high-potency vitamin, the assay, the related substances and the peroxide value are qualified across the process so the vitamin's stability is demonstrated rather than simply assumed.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation for the aqueous services, qualified clean-oil handling and de-aeration, qualified HVAC with continuous environmental monitoring, validated dry-heat sterilisation and aseptic ampoule-filling equipment with nitrogen blanketing and 100 % inspection, sterilising-grade filtration with filter-integrity testing, controlled light-protected compounding and holding, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Because a fat-soluble vitamin is injected as a depot into muscle and its potency depends on an intact, un-oxidised molecule delivered at the labelled IU, we treat the assay, the related substances, the peroxide value, the colour and the deliverable volume as critical quality attributes and trend them across batches, not merely as one-off release tests. Stability is tracked under ICH Q1A long-term and accelerated conditions and ICH Q1B photostability, with the assay, related substances and colour followed across the study, so the solution stays clear, correctly potent and within specification across the labelled shelf life, and the protect-from-light storage instructions on the label are supported by real data.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Cholecalciferol (Vitamin D3) Injection manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables, including a broad vitamin, endocrine and general-injectables portfolio. For Cholecalciferol (Vitamin D3) Injection specifically, we supply the fat-soluble vitamin D3 as a high-potency 300,000 IU/mL oily solution, together with 600,000 IU and other strengths and fill volumes, under WHO-GMP conditions, with country-specific strengths, fill volumes, tamper-evident packs and pack counts available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier - including the high-potency-assay, related-substance, oxidation, photostability, sterilisation and container-closure data package - ready to hand for registration and tender qualification. Buyers evaluating Cholecalciferol (Vitamin D3) Injection can request the assay, related-substance and accelerated-stability summaries up front, which is often the deciding technical evidence for a fat-soluble vitamin injectable in hospital-formulary and ministry-of-health review, since it is the confirmed IU of an un-oxidised vitamin and a validated sterility assurance that separate a dependable vitamin D injection from an unreliable one.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability data, ICH Q1B photostability data, forced-degradation and oxidation packages, sterilisation and container-closure reports, translated package inserts and artwork - including the deep-intramuscular administration instruction, the intramuscular-only (not-for-intravenous-use) caution of an oily injection, the protect-from-light storage directions and the dosing-interval guidance for high-dose depot therapy - for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics to the destination market. When a buyer needs Cholecalciferol (Vitamin D3) Injection at tender scale our regulatory, manufacturing and logistics teams move as one: dossier, validation reports, artwork, line slot and shipment schedule delivered as a single coordinated package.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor and into the nitrogen-protected, light-controlled oil-compounding and filling suites; our quality unit answers technical queries with primary data, not slogans; and our reviewer team - practising pharmacists and R&D scientists - can talk through cholecalciferol sourcing and pre-existing-degradation control, the qualification of the injectable oil vehicle, the design of an antioxidant-protected, nitrogen-blanketed fat-soluble vitamin solution, the high-potency assay and vitamin D-related-substance strategy by HPLC, the validation of dry-heat or aseptic sterilisation for a non-aqueous product, colour, peroxide-value and particulate control, photostability, potency overage and fill accuracy, endotoxin control, container-closure integrity and shelf-life choices in real detail. For a fat-soluble vitamin depot where assay accuracy, oxidation control and IU stability directly govern potency and safety, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Cholecalciferol (Vitamin D3) Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Cholecalciferol (Vitamin D3) Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, validated water-for-injection systems, qualified clean-oil handling, nitrogen-blanketed and light-protected non-aqueous compounding and ampoule filling, sterilising-grade filtration, validated dry-heat or aseptic sterilisation, 100 % inspection and continuous environmental monitoring.
Which strengths and presentations of Cholecalciferol (Vitamin D3) Injection do you supply?
Our fat-soluble vitamin D3 solution is available as a high-potency 300,000 IU/mL (7.5 mg/mL) oily solution in amber glass ampoules, with 600,000 IU and other strengths and fill volumes for deep intramuscular use. Custom strengths, fill volumes, container formats, tamper-evident counts per pack and country-specific artwork are available under contract manufacturing agreements.
What is Cholecalciferol (Vitamin D3) Injection mainly used for?
Cholecalciferol (Vitamin D3) Injection is used to correct severe vitamin D deficiency and its consequences - nutritional rickets, osteomalacia, and the deficiency of malabsorption or of chronic liver or kidney disease - as a single long-acting intramuscular depot when the oral route is unreliable. It is given by deep intramuscular injection only, never intravenously; Farbe Firma verifies the assay and delivered IU, the vitamin D-related substances, the oil peroxide value, colour and clarity, particulate matter and endotoxin at release so each ampoule delivers a correctly potent, oxidation-free solution. Dosing and the interval between high doses are set by the prescriber to avoid hypercalcaemia and vitamin D toxicity.
Can Farbe Firma support country-specific registrations for Cholecalciferol (Vitamin D3) Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability data, ICH Q1B photostability data, related-substance, oxidation and forced-degradation packages, sterilisation and container-closure reports, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. We support registrations and tender qualification in 30+ countries across Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
What is the minimum order quantity for Cholecalciferol (Vitamin D3) Injection contract manufacturing?
MOQs vary by strength, fill volume, label complexity and dossier requirements. For our oily-solution ampoule presentations we accommodate hospital-scale and full national-tender-scale orders. Contact director@farbefirma.org for a specific quotation.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments